How Supplied
INFLECTRA (infliximab-dyyb) for injection is supplied as one single-dose vial individually packaged in a carton (NDC 0069-0809-01 100 mg vial).
Each single-dose vial contains 100 mg of infliximab-dyyb as a sterile, preservative-free, white lyophilized powder for reconstitution and dilution (more than one vial may be needed for a full dose) [see Dosage and Administration (2.11)].
Storage and Handling
Store unopened INFLECTRA vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
If needed, unopened INFLECTRA vials may be stored at room temperature up to a maximum of 30°C (86°F) for a single period up to 6 months but not exceeding the original expiration date. The new expiration date must be written in the space provided on the carton. Once removed from the refrigerator, INFLECTRA cannot be returned to the refrigerator.
Not made with natural rubber latex.
For storage condition of the reconstituted and diluted product for administration, see Dosage and Administration (2.11).
How Supplied
INFLECTRA (infliximab-dyyb) for injection is supplied as one single-dose vial individually packaged in a carton (NDC 0069-0809-01 100 mg vial).
Each single-dose vial contains 100 mg of infliximab-dyyb as a sterile, preservative-free, white lyophilized powder for reconstitution and dilution (more than one vial may be needed for a full dose) [see Dosage and Administration (2.11)].
Storage and Handling
Store unopened INFLECTRA vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
If needed, unopened INFLECTRA vials may be stored at room temperature up to a maximum of 30°C (86°F) for a single period up to 6 months but not exceeding the original expiration date. The new expiration date must be written in the space provided on the carton. Once removed from the refrigerator, INFLECTRA cannot be returned to the refrigerator.
Not made with natural rubber latex.
For storage condition of the reconstituted and diluted product for administration, see Dosage and Administration (2.11).
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.